• Gain a better understanding of the current state and utilization of ion channel safety assessment tools.
• Enables preclinical safety leaders across the industry to engage in pre-competitive, and collaborative learning through the sharing of collective experiences and insights
• Clients incur only a fraction of the cost when compared to a similar client-specific consulting arrangement.
• The opportunity to have up to ten (10) real world compounds tested with the Millipore technology free of charge.  In addition, participating companies of this project can receive a 100% reimbursement of their investment in the form of a 30% discount on future Millipore ion channels assay screens for predicative cardiotoxicology, divided equally over the next three years.
• Potential for tremendous cost savings in terms of human resources saved by being able to pick safer compounds for further studies long before ramp up to in vivo toxicology testing.
• Opportunity to directly influence the design optimization and validation of this technology to meet their preclinical safety assessment needs.

 Download Full Project Description                                                                         Contact Us

Previous Page    Back to Project Description    Next Page